Cabaletta Bio director granted 22,000 stock options
Cabaletta Bio director Catherine Bollard received a stock option grant covering 22,000 shares of common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Cabaletta Bio director Catherine Bollard received a stock option grant covering 22,000 shares of common stock. The option has an exercise price of $3.22 per share and gives her the right to buy 22,000 shares in the future. It vests in full on the earlier of June 9, 2027 or the date of the company’s next annual stockholder meeting, providing equity-based compensation rather than an open-market share purchase.
Insider Trade Summary
Grant/Award: 22,000 shares
Grant/Award
1 txn
Insider
Bollard Catherine
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 22,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 22,000 contracts (Direct)
Footnotes (1)
- F1. This option shall vest in full upon the earlier of (i) June 9, 2027 or (ii) the date of the next annual meeting of the Corporation's stockholders.
Key Figures
Option grant size: 22,000 options
Exercise price: $3.22 per share
Underlying shares: 22,000 shares
+2 more
5 metrics
Option grant size
22,000 options
Stock Option (Right to Buy) covering common stock
Exercise price
$3.22 per share
Conversion or exercise price of the option
Underlying shares
22,000 shares
Underlying Cabaletta Bio common stock
Expiration date
June 8, 2036
Option expiration date
Shares following transaction
22,000 options
Total derivative securities after this grant
Key Terms
Stock Option (Right to Buy), exercise price, expiration date, underlying security, +1 more
5 terms
Stock Option (Right to Buy) financial
"security_title: "Stock Option (Right to Buy)""
exercise price financial
"conversion_or_exercise_price: "3.2200" per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: "2036-06-08T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
underlying security financial
"underlying_security_title: "Common Stock""
vest in full financial
"This option shall vest in full upon the earlier of (i) June 9, 2027 or (ii) the date of the next annual meeting"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Cabaletta Bio (CABA) report for Catherine Bollard?
Cabaletta Bio reported that director Catherine Bollard received a stock option grant for 22,000 shares. The options are a compensation award, not an open-market purchase, and give her the right to buy common stock at a fixed exercise price in the future.
How many Cabaletta Bio (CABA) options did Catherine Bollard receive and at what price?
Catherine Bollard was granted stock options covering 22,000 shares of Cabaletta Bio common stock. The options carry an exercise price of $3.22 per share, setting the cost she must pay per share if she later chooses to exercise them.
When do Catherine Bollard’s Cabaletta Bio (CABA) stock options vest?
Catherine Bollard’s options vest in full on the earlier of June 9, 2027, or the date of Cabaletta Bio’s next annual stockholder meeting. She must wait until this vesting event before the entire 22,000-share option becomes exercisable.
What is the expiration date of Catherine Bollard’s Cabaletta Bio (CABA) stock options?
The stock options granted to Catherine Bollard expire on June 8, 2036. If she does not exercise the 22,000 options by that expiration date at the $3.22 exercise price, the right to purchase the underlying shares will lapse.
How many Cabaletta Bio (CABA) options does Catherine Bollard hold after this grant?
Following this grant, Catherine Bollard’s reported holdings include 22,000 stock options. These options relate to 22,000 underlying Cabaletta Bio common shares and represent her position from this filing, subject to vesting and the stated expiration date in 2036.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates